P

Inventor

COLE ANDREW G

US12 patents
⚠️ This page may combine multiple inventors who share the name “COLE ANDREW G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LIGAND PHARM INC

5 patents
US10030034B2Jul 24, 2018

Heterocycle amines and uses thereof

LIGAND PHARM INC5 citations82
US11186593B2Nov 30, 2021

Heterocycle amines and uses thereof

LIGAND PHARM INC1 citations71
US10604533B2Mar 31, 2020

Heterocycle amines and uses thereof

LIGAND PHARM INC1 citations71
US11773110B2Oct 3, 2023

Heterocycle amines and uses thereof

LIGAND PHARM INC0 citations61
US9266874B2Feb 23, 2016

Heterocycle amines and uses thereof

LIGAND PHARM INC2 citations61

ARBUTUS BIOPHARMA CORP

3 patents
US11566002B2Jan 31, 2023

Substituted tetrahydrocyclopenta[C]pyrroles, substituted dihydropyrrolizines, analogues thereof, and methods using same

ARBUTUS BIOPHARMA CORP1 citations56
US11098010B2Aug 24, 2021

Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same

ARBUTUS BIOPHARMA CORP0 citations46
US11001564B2May 11, 2021

Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same

ARBUTUS BIOPHARMA CORP0 citations45

VENENUM BIODESIGN LLC

2 patents
US11236055B2Feb 1, 2022

Non-systemic TGR5 agonists

VENENUM BIODESIGN LLC0 citations47
US10669242B2Jun 2, 2020

Clostridium difficile toxin inhibitors

VENENUM BIODESIGN LLC0 citations30

SIGNAL PHARM LLC

1 patent
US7723340B2May 25, 2010

Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith

SIGNAL PHARM LLC46 citations91

PHARMACOPEIA LLC

1 patent
US7951803B2May 31, 2011

8-heteroarylpurine MNK2 inhibitors for treating metabolic disorders

PHARMACOPEIA LLC10 citations78